July 8, 2025

Reducing Pharmaceutical Recalls with Smart Labels: A Digital Solution to Labeling Errors

Labeling errors are among the top causes of pharmaceutical recalls. Discover how ForgeStop’s smart label technology allows real-time updates, consumer alerts, and fewer recalls—ushering in a smarter future for compliance and brand trust.

Introduction

Pharmaceutical recalls are a costly and dangerous reality in the industry, with labeling errors ranking as one of the top causes. Once a mislabeled product hits the market, there is only one option: a recall. These incidents not only affect public health but also erode consumer trust and damage brand reputation.

However, there is a better way forward. Digital smart labels—like those offered by ForgeStop—allow brands to correct label information in real time and even alert consumers instantly, reducing the impact of errors and enabling smarter recalls.

The Problem with Traditional Labels

Labeling errors are responsible for a significant portion of pharmaceutical recalls. According to FDA data, labeling issues account for between 8% and 42% of recalls depending on the reporting parameters. These can include incorrect dosages, missing instructions, or packaging mismatches.

Once these products are distributed, there's no way to retroactively fix the printed label. The only available solution is to initiate a recall—a process that is not only expensive but also logistically complex and reputationally damaging.

A New Era of Digital Labeling

Smart labels using NFC (Near Field Communication) technology are changing the game. ForgeStop’s smart labeling platform replaces static information with dynamic, cloud-connected data that can be updated in real time.

Key Benefits:

  • Real-Time Amendments: Instantly update digital label content without changing the physical packaging.
  • One-Tap Consumer Alerts: Consumers can be notified directly when they scan the label using any NFC-enabled smartphone—no app required.
  • Regulatory Flexibility: Ensure fast, accurate, and compliant updates across global markets.
  • Traceability and Insights: Track product distribution and user interaction, and identify issues early.

📖 Related: Digital Product Passports for Traceability
📖 Explore: How NFC Works for Product Authentication

Use Case Example: Instant Recall Communication

Imagine a batch of medication is discovered to have an outdated dosage instruction. Instead of recalling every unit, a brand using ForgeStop’s smart label technology can instantly push an update to the digital label. The next time a consumer or pharmacist taps the product, they see corrected information—and are even given clear next steps if a recall is in progress.

A Safer, Smarter Future for Pharma

The shift from printed to digital labeling is not just a convenience—it’s a safeguard. By adopting smart labels, pharmaceutical companies gain the flexibility to respond to issues in real time, reduce unnecessary recalls, and improve consumer trust.

As the pharmaceutical industry continues to innovate, it’s time labeling caught up.

Ready to future-proof your labeling strategy? Contact ForgeStop today to see how our smart label technology can protect your brand and your customers.

📘 Frequently Asked Questions

What other benefits do smart labels offer in pharma?
Beyond recalls, they enhance regulatory compliance, provide lifecycle traceability, and improve transparency between brands and consumers.
What happens during a product recall using smart labels?
Brands can push alerts to consumers and retailers instantly, providing next steps, safety instructions, and recall information the moment a product is scanned.
Do consumers need to download an app to use smart labels?
No. ForgeStop’s solution works with any NFC-enabled smartphone—just tap and go.
Can digital labels really be updated after distribution?
Yes. ForgeStop’s smart labels are connected to the cloud and can be updated in real time without changing the physical packaging.
How common are pharmaceutical recalls due to labeling errors?
Labeling-related issues account for 8% to 42% of all pharmaceutical recalls, depending on definitions and data sources.